As an endogenous immunometabolite, itaconate has excellent anti-inflammatory effects. However, it remains unknown whether itaconate protects against atherosclerosis. Two recent studies, by Song et al. and Cyr et al., revealed the emerging role of the aconitate decarboxylase 1/itaconate pathway in atherosclerosis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.molmed.2024.05.015 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!